Virtus Biotech Clinical Trials ETF (BBC): ETF
ETF traded on ARCX under symbol BBC. Quoted in usd.
Virtus Biotech Clinical Trials ETF
+5.62%$43.02
ARCX:BBCSector Equity
AUM $26.54M·YTD --·Yield --
ARCX:BBC$43.02+5.62%AUM $26.54MTop Holdings
17.1% of portfolio in top 10 holdings
Concentrated in Healthcare (100.0%)
Performance:
 | XNCR Xencor Inc | +46.76% | 17.6K | |
 | KOD Kodiak Sciences Inc | +7.54% | 6.4K | |
 | TRAX First Tracks Biotherapeutics Inc | +52.60% | 12.3K | |
 | REPL Replimune Group Inc | +63.17% | 24.4K | |
 | ABCL AbCellera Biologics Inc | -9.66% | 41.4K | |
 | AMLX Amylyx Pharmaceuticals Inc | +5.21% | 14.9K | |
 | SGP SpyGlass Pharma Inc | +49.09% | 11.8K | |
 | VRDN Viridian Therapeutics Inc | +56.37% | 13.3K | |
 | PRME Prime Medicine Inc | +32.86% | 78.1K | |
 | KYMR Kymera Therapeutics Inc | +24.30% | 2.5K | |
 | PVLA Palvella Therapeutics Inc | +37.44% | 2.0K | |
 | ORKA Oruka Therapeutics Inc | +28.29% | 3.1K | |
 | MBX MBX Biosciences Inc | -9.79% | 6.1K | |
 | MAZE Maze Therapeutics Inc | +29.36% | 9.0K | |
 | LBRX LB Pharmaceuticals Inc | +22.62% | 7.6K | |
 | MANE VeraDermics Inc | +27.37% | 2.3K | |
 | SEPN Septerna Inc | +36.95% | 6.0K | |
 | ZBIO Zenas Biopharma Inc | +4.90% | 11.0K | |
 | PCVX Vaxcyte Inc | -4.21% | 4.6K | |
 | VOR Vor BioPharma Inc | +8.57% | 15.1K | |
 | VIR Vir Biotechnology Inc | +5.26% | 25.2K | |
 | FDMT 4D Molecular Therapeutics Inc | -2.47% | 24.6K | |
 | BHVN Biohaven Ltd | +19.87% | 19.2K | |
 | DFTX Definium Therapeutics Inc | -6.60% | 8.8K | |
 | SYRE Spyre Therapeutics Inc | +29.65% | 2.7K |
Institutional Holders
Sector Breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.00% |
Holdings Treemap
Country Allocation
| Country | Weight |
|---|---|
| United States | 90.72% |
| Canada | 2.34% |
| United Kingdom | 1.97% |
| Netherlands | 1.96% |
| Ireland | 1.43% |
| Switzerland | 1.00% |
| China | 0.59% |